|
C1ORF174 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.544200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.210000E-01 |
| Normal-vs-Stage2 |
1.664370E-01 |
| Normal-vs-Stage3 |
2.159600E-02 |
| Normal-vs-Stage4 |
1.663240E-01 |
| Stage1-vs-Stage2 |
5.152400E-01 |
| Stage1-vs-Stage3 |
1.592610E-01 |
| Stage1-vs-Stage4 |
4.552800E-01 |
| Stage2-vs-Stage3 |
5.616200E-01 |
| Stage2-vs-Stage4 |
7.724600E-01 |
| Stage3-vs-Stage4 |
8.605400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.461850E-01 |
| Normal-vs-AfricanAmerican |
6.527200E-01 |
| Normal-vs-Asian |
2.976400E-02 |
| Caucasian-vs-AfricanAmerican |
5.587200E-01 |
| Caucasian-vs-Asian |
4.801800E-01 |
| AfricanAmerican-vs-Asian |
3.558600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.334400E-01 |
| Normal-vs-Female |
4.535000E-01 |
| Male-vs-Female |
7.843600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.682950E-01 |
| Normal-vs-Extreme_Weight |
9.997700E-02 |
| Normal-vs-Obese |
5.424000E-01 |
| Normal-vs-Extreme_Obese |
5.344000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.258600E-01 |
| Normal_Weight-vs-Obese |
5.014600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.857200E-01 |
| Extreme_Weight-vs-Obese |
4.739600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.426600E-01 |
| Obese-vs-Extreme_Obese |
6.924800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.335800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.277200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.219790E-01 |
| Normal-vs-Age(81-100Yrs) |
5.622000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.280200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.808600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.504200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.591350E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.481600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.451400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.890400E-01 |
| Normal-VS-Type2 PRCC |
6.756300E-04 |
| Normal-VS-KIRP CIMP |
9.295900E-02 |
| Normal-VS-Unclassified PRCC |
5.541200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.179840E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.227800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.135600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.291600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.610300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.455800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.264300E-03 |
| Normal-vs-N1 |
1.061000E-01 |
| Normal-vs-N2 |
4.617500E-04 |
| N0-vs-N1 |
5.715200E-01 |
| N0-vs-N2 |
1.437630E-01 |
| N1-vs-N2 |
7.711500E-02 |
|
|
